Francesco Dazzi

Francesco Dazzi is a prominent figure in the field of cell therapy and currently serves as the Executive Medical Lead for Cell Therapies at AstraZeneca.16 With an extensive background in regenerative and haematological medicine, Dazzi is recognized as an established Cell Therapy expert and a Key Opinion Leader (KOL) in the field.1

Professional Background

Dazzi's career is marked by significant contributions to cellular therapy research and development. He is responsible for guiding AstraZeneca's clinical application strategies in cell therapy6, leveraging his expertise to advance innovative treatments.

Education and Expertise

Francesco Dazzi received his education from the University of Padua1, which has likely contributed to his strong foundation in medical science. His area of specialization includes:

• Regenerative medicine
• Haematological medicine
• Cellular therapies

Academic Affiliations

In addition to his role at AstraZeneca, Dazzi holds academic positions:

• Professor of Regenerative and Haematological Medicine
• KHP Lead for Cellular Therapies5
• Adjunct Professor at SCMMS Denmark Hill7

Research Impact

Dazzi's contributions to the scientific community are substantial, as evidenced by his high publication record.1 His research has garnered significant attention, with over 13,968 citations to his work7, underscoring the impact and relevance of his studies in the field of cell therapy.

Industry Involvement

At AstraZeneca, Dazzi is actively involved in various initiatives:

• Overseeing the R&D Postdoctoral Challenge, which supports early career scientists2
• Participating in conferences such as NECA San Diego, where he engages with other professionals in the field4
• Contributing to discussions on critical issues like the climate health crisis3

Francesco Dazzi's expertise in cell therapy, combined with his roles in academia and industry, positions him as a leading figure in advancing cellular therapies and their clinical applications.